PubRank

M Cescon

Author PubWeight™ 29.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 2008 2.06
2 Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 2001 1.66
3 An appraisal of percutaneous treatment of liver metastases. Liver Transpl Surg 1998 1.54
4 Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant 2008 1.27
5 Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant 2010 1.18
6 Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? Am J Transplant 2011 1.18
7 Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. Eur J Surg Oncol 2005 1.08
8 Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology 2000 1.05
9 Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther 2003 1.05
10 The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. Surgery 2000 1.00
11 The use of social networking to explore knowledge and attitudes toward organ donation in Italy. Minerva Anestesiol 2012 0.97
12 Isolated resection of segment 8 for liver tumors: a new approach for anatomical segmentectomy. Arch Surg 2000 0.94
13 Safety of hepatic resection in overweight and obese patients with cirrhosis. Br J Surg 2011 0.90
14 Sirolimus in liver transplant recipients: a large single-center experience. Transplant Proc 2010 0.89
15 Liver transplantation with the Meld system: a prospective study from a single European center. Am J Transplant 2006 0.89
16 The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients. Minerva Chir 2009 0.85
17 A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant 2001 0.82
18 Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation. Aliment Pharmacol Ther 2008 0.81
19 Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. Transplant Proc 2010 0.81
20 Splenoadrenal shunt. An original portosystemic decompressive technique. Hepatogastroenterology 2001 0.80
21 Efficacy of MELD score in predicting survival after liver retransplantation. Transplant Proc 2004 0.80
22 Bacterial translocation in adult small bowel transplantation. Transplant Proc 2009 0.80
23 Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center. Transplant Proc 2004 0.79
24 Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. Transplant Proc 2010 0.79
25 Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants. Transplant Proc 2005 0.78
26 Isolated intestinal transplant for chronic intestinal pseudo-obstruction in adults: long-term outcome. Transplant Proc 2013 0.78
27 Twenty-seven consecutive intestinal and multivisceral transplants in adult patients: a 4-year clinical experience. Transplant Proc 2005 0.77
28 Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients. Transplant Proc 2010 0.77
29 Using elderly donors in liver transplantation. Transplant Proc 2005 0.77
30 Role of real-time contrast-enhanced ultrasound in the assessment of metastatic portal vein thrombosis. Ultraschall Med 2007 0.76
31 Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria (Br J Surg 2011; 98: 1201-1208). Br J Surg 2011 0.76
32 Coping strategies in intestinal transplantation. Transplant Proc 2007 0.75
33 Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers. Transplant Proc 2008 0.75
34 [Liver transplantation from elderly donors]. Chir Ital 1999 0.75
35 Surgical approach to complicated intestinal failure for benign disease in adult patients: transplantation or surgical rehabilitation? Transplant Proc 2006 0.75
36 Recovery from liver dysfunction after adult isolated intestinal transplantation without liver grafting. Transplant Proc 2006 0.75
37 Successful liver transplantation using an 87 year-old donor. Hepatogastroenterology 1999 0.75
38 Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. Transplant Proc 2007 0.75
39 Steroids in intestinal transplantation. Clin Transplant 2007 0.75
40 Acute cellular rejection monitoring after intestinal transplant: utility of serologic markers and zoom videoendoscopy as support of conventional biopsy and clinical findings. Transplant Proc 2008 0.75
41 Psychological adaptation and quality of life of adult intestinal transplant recipients: University of Bologna experience. Transplant Proc 2010 0.75
42 Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. Transplant Proc 2010 0.75
43 Assessment of perioperative transfusion requirement for cirrhotic patients undergoing elective hepatectomy. Minerva Anestesiol 2013 0.75
44 Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. Dig Liver Dis 2007 0.75
45 Induction therapy with alemtuzumab (campath) in combined liver-kidney transplantation: University of Bologna experience. Transplant Proc 2013 0.75
46 Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. Transplant Proc 2007 0.75
47 Results of intestinal and multivisceral transplantation in adult patients: Italian experience. Transplant Proc 2006 0.75
48 Induction therapy in adult intestinal transplantation: reduced incidence of rejection with "2-dose" alemtuzumab protocol. Clin Transplant 2013 0.75
49 Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience. Clin Transplant 2007 0.75